Point72 Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-458,712
Closed -$1.24M 4051
2025
Q4
$1.24M Buy
458,712
+291,129
+174% +$956K ﹤0.01% 2758
2025
Q3
$709K Sell
167,583
-338,317
-67% -$1.49M ﹤0.01% 1800
2025
Q2
$2.52M Buy
505,900
+67,643
+15% +$294K ﹤0.01% 1203
2025
Q1
$1.93M Buy
438,257
+56,354
+15% +$264K ﹤0.01% 1254
2024
Q4
$1.78M Sell
381,903
-1,245,687
-77% -$6.85M ﹤0.01% 1286
2024
Q3
$11.3M Buy
+1,627,590
New +$12.8M 0.03% 606
2023
Q3
Sell
-3
Closed -$17 2611
2023
Q2
$17 Buy
+3
New +$16 ﹤0.01% 2094
2022
Q1
Sell
-250,269
Closed -$8.18M 1241
2021
Q4
$8.18M Buy
+250,269
New +$10.1M 0.03% 560
2020
Q4
Sell
-115,000
Closed -$6.39M 995
2020
Q3
$6.39M Buy
+115,000
New +$6.09M 0.03% 508

Other funds holding GDRX

Point72 Asset Management's GDRX Position: Q1 2026 in Review

Point72 Asset Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 458,712 shares — an estimated $1.24M sold.

Point72 Asset Management first reported a position in GDRX in Q3 2020 and held it in 9 quarters. The position peaked at $11.3M in Q3 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Point72 Asset Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 458,712 GoodRx Holdings shares in Q1 2026, an estimated $1.24M.
  • Point72 Asset Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 9 quarters.
  • Point72 Asset Management's GoodRx Holdings position peaked at $11.3M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.